Poly Medicure Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 4/6
Poly Medicure verzeichnete einen durchschnittlichen jährlichen Gewinnzuwachs von 23.2%, während die Gewinne der Branche Medical Equipment jährlich um gewachsen und zwar um 17.6%. Die Umsätze verzeichneten einen durchschnittlichen jährlichen Gewinnzuwachs von gewachsen von 17.4%. Die Eigenkapitalrendite von Poly Medicure beträgt 11.4% und die Nettomargen betragen 19.4%.
Wichtige Informationen
23.2%
Wachstumsrate der Gewinne
21.2%
EPS-Wachstumsrate
| Medical Equipment Wachstum der Industrie | 23.0% |
| Wachstumsrate der Einnahmen | 17.4% |
| Eigenkapitalrendite | 11.4% |
| Netto-Marge | 19.4% |
| Letzte Ertragsaktualisierung | 30 Sep 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Why Investors Shouldn't Be Surprised By Poly Medicure Limited's (NSE:POLYMED) 33% Share Price Surge
Nov 02
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 20Poly Medicure (NSE:POLYMED) Will Pay A Dividend Of ₹3.00
Sep 14After Leaping 41% Poly Medicure Limited (NSE:POLYMED) Shares Are Not Flying Under The Radar
Sep 06Poly Medicure (NSE:POLYMED) Has A Pretty Healthy Balance Sheet
Aug 14Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹2,138
Jul 27Investors Still Waiting For A Pull Back In Poly Medicure Limited (NSE:POLYMED)
Jul 11Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations
May 25Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital
May 12Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up
Mar 23Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today
Feb 15Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 16Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?
Nov 14Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward
Oct 24Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 22Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Aug 12Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching
Jul 13Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return
Jun 16Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital
Mar 02We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Feb 14Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal
Oct 16We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Sep 28Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Jun 25A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)
Jun 07Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends
May 23With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Feb 23There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital
Feb 04Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 12With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Oct 14Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt
Jul 07Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends
Jun 18Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals
May 31Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195
May 26Aufschlüsselung der Einnahmen und Ausgaben
Wie Poly Medicure Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 30 Sep 24 | 15,225 | 2,949 | 2,844 | 189 |
| 30 Jun 24 | 14,397 | 2,696 | 2,590 | 188 |
| 31 Mar 24 | 13,758 | 2,583 | 2,516 | 190 |
| 31 Dec 23 | 13,046 | 2,487 | 2,349 | 198 |
| 30 Sep 23 | 12,498 | 2,337 | 2,278 | 193 |
| 30 Jun 23 | 11,872 | 2,150 | 2,151 | 182 |
| 31 Mar 23 | 11,152 | 1,793 | 2,076 | 178 |
| 31 Dec 22 | 10,659 | 1,566 | 1,979 | 171 |
| 30 Sep 22 | 10,113 | 1,411 | 1,866 | 178 |
| 30 Jun 22 | 9,600 | 1,359 | 1,751 | 188 |
| 31 Mar 22 | 9,231 | 1,465 | 1,671 | 188 |
| 31 Dec 21 | 8,785 | 1,492 | 1,590 | 174 |
| 30 Sep 21 | 8,518 | 1,500 | 1,544 | 159 |
| 30 Jun 21 | 8,280 | 1,468 | 1,489 | 140 |
| 31 Mar 21 | 7,865 | 1,359 | 1,448 | 131 |
| 31 Dec 20 | 7,448 | 1,197 | 1,434 | 129 |
| 30 Sep 20 | 7,218 | 1,094 | 1,409 | 124 |
| 30 Jun 20 | 6,960 | 1,028 | 1,359 | 121 |
| 31 Mar 20 | 6,872 | 959 | 1,431 | 119 |
| 31 Dec 19 | 6,881 | 947 | 1,427 | 97 |
| 30 Sep 19 | 6,625 | 858 | 1,377 | 98 |
| 30 Jun 19 | 6,388 | 719 | 1,229 | 100 |
| 31 Mar 19 | 6,108 | 654 | 1,224 | 101 |
| 31 Mar 18 | 5,204 | 706 | 1,035 | 100 |
| 31 Mar 17 | 4,550 | 551 | 931 | 90 |
| 31 Mar 16 | 4,123 | 483 | 791 | 87 |
| 31 Mar 15 | 3,903 | 623 | 687 | 85 |
| 31 Mar 14 | 3,222 | 451 | 784 | 59 |
Qualität der Erträge: POLYMED einen hohen Anteil an unbarem Gewinn hat.
Wachsende Gewinnspanne: POLYMEDDie aktuellen Gewinnspannen (19.4%) sind höher als im letzten Jahr (18.7%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: POLYMEDIn den letzten 5 Jahren sind die Einnahmen von 23.2% pro Jahr erheblich gestiegen.
Beschleunigtes Wachstum: POLYMEDDas Gewinnwachstum des Unternehmens im letzten Jahr (26.2%) übertrifft seinen 5-Jahres-Durchschnitt (23.2% pro Jahr).
Erträge im Vergleich zur Industrie: POLYMED Das Gewinnwachstum im vergangenen Jahr (26.2%) übertraf das der Branche Medical Equipment 8.8% .
Eigenkapitalrendite
Hohe Eigenkapitalrendite: POLYMEDDie Eigenkapitalrendite des Unternehmens (11.4%) wird als niedrig angesehen.